ATAD1 and malaria: These data provide the first strong evidence that the in vitro GIA assay can correlate with outcome against blood-stage P. falciparum CHMI in vaccinated humans; this is highly consistent with previous non-human primate studies that also assessed MSP1, AMA1, or RH5 vaccine efficacy against blood-stage malaria challenge.17